Clinical impact of cell-free serum Epstein–Barr virus status in patients with newly diagnosed malignant lymphoma

BACKGROUND: We analyzed cell-free serum Epstein‒Barr virus (EBV) DNA to identify its prognostic role in patients with newly diagnosed lymphoma. METHODS: We retrospectively reviewed patients diagnosed with lymphoma between January 2014 and July 2020. Patients were enrolled according to the following...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Res
Egile Nagusiak: Baek, Dong Won, Lee, Jung Min, Kim, Juhyung, Cho, Hee Jeong, Sohn, Sang Kyun, Ham, Ji Yeon, Chang, Soon Hee, Moon, Joon Ho, Yang, Deok-Hwan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8246039/
https://ncbi.nlm.nih.gov/pubmed/34031277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2021.2021028
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak